Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy

Information

  • Research Project
  • 9622376
  • ApplicationId
    9622376
  • Core Project Number
    R44CA233143
  • Full Project Number
    1R44CA233143-01
  • Serial Number
    233143
  • FOA Number
    PA-17-302
  • Sub Project Id
  • Project Start Date
    8/6/2018 - 5 years ago
  • Project End Date
    2/5/2019 - 5 years ago
  • Program Officer Name
    HALLETT, KORY L
  • Budget Start Date
    8/6/2018 - 5 years ago
  • Budget End Date
    2/5/2019 - 5 years ago
  • Fiscal Year
    2018
  • Support Year
    01
  • Suffix
  • Award Notice Date
    8/6/2018 - 5 years ago

Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R44
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    218588
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    396
  • Ed Inst. Type
  • Funding ICs
    NCI:218588\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    B-MOGEN BIOTECHNOLOGIES, INC.
  • Organization Department
  • Organization DUNS
    079960066
  • Organization City
    Minneapolis
  • Organization State
    MN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    554132610
  • Organization District
    UNITED STATES